BNP Paribas Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $43.1M | Buy |
|
|||||
|
2025
Q2 | $22.3M | Buy |
|
|||||
|
2025
Q1 | $21M | Buy |
|
|||||
|
2024
Q4 | $23M | Buy |
|
|||||
|
2024
Q3 | $17.3M | Sell |
|
|||||
|
2024
Q2 | $20.8M | Buy |
|
|||||
|
2024
Q1 | $24.9M | Sell |
|
|||||
|
2023
Q4 | $39M | Sell |
|
|||||
|
2023
Q3 | $18.2M | Buy |
|
|||||
|
2023
Q2 | $14M | Sell |
|
|||||
|
2023
Q1 | $19.9M | Sell |
|
|||||
|
2022
Q4 | $27.5M | Sell |
|
|||||
|
2022
Q3 | $30.5M | Sell |
|
|||||
|
2022
Q2 | $25.7M | Sell |
|
|||||
|
2022
Q1 | $29.2M | Sell |
|
|||||
|
2021
Q4 | $38.3M | Buy |
|
|||||
|
2021
Q3 | $29.4M | Sell |
|
|||||
|
2021
Q2 | $21.7M | Buy |
|
|||||
|
2021
Q1 | $21.1M | Buy |
|
|||||
|
2020
Q4 | $13.2M | Buy |
|